- Conagra Brands Inc (NYSE:CAG) reported fourth-quarter FY22 sales growth of 6.2% year-on-year to $2.91 billion, missing the consensus of $2.93 billion.
- Grocery & Snacks segment sales increased 7.2% Y/Y to $1.2 billion, and Refrigerated & Frozen segment sales increased 3.4% Y/Y to $1.2 billion.
- Adjusted EPS of $0.65 beat the consensus of $0.63.
- Adjusted gross profit rose 0.3% to $723 million. The gross margin decreased 183 basis points Y/Y to 24.5%, and the adjusted gross margin decreased 147 basis points to 24.9%.
- Adjusted operating margin expanded 96 basis points Y/Y to 15%.
- The company reported $499.3 million in selling, general, and administrative expenses, a 14.7% increase Y/Y.
- Adjusted EBITDA of $591 million increased 13.5% Y/Y.
- Cash and equivalents totaled $83.3 million as of May 29, 2022.
- Outlook: Conagra sees FY23 organic net sales growth of 4% – 5%.
- Conagra expects FY23 adjusted EPS growth of 1% – 5%.
- CAG expects cost of goods sold inflation to continue into FY23.
- Price Action: CAG shares are trading lower by 2.35% at $34.90 in premarket on the last check Thursday.
- Photo Via Wikimedia
Why Endo International Shares Are Getting Hammered Today
Endo International PLC (NASDAQ: ENDP) shares are trading lower by 16.86% to $0.39 after the company provided top-line results from its Phase 2 study of CCH in patients with adhesive capsulitis of the shoulder, saying "the difference compared to those study participants receiving placebo was not st
